IDIs: self-injectable needle packaging with consumers and HCPs

Our client was supporting the manufacturer of self-injectable anti-obesity medication (a type of GLP-1 agonist), with the intention of exploring the way their needles are packaged. The manufacturer was looking to decide if the needles should be packaged in the same box as the syringes containing the medication, in a separate box, and also explore how the needles should be laid out inside the box.

The client wanted to conduct online surveys with two target groups in the USA and Germany:

- Patients with a body mass index (BMI) of 30+ (half of whom had experience of using a self-injectable device, and half of whom were device-naïve).

- Nurses who regularly see patients with obesity and help train them on administering self-injectable devices.

We were also asked to arrange a number of pilot interviews, where a professional moderator talked each participant through the survey and noted down any areas of difficulty. This was to ensure that the questions asked during the online survey were properly understood by both target groups, and could be improved upon for the final interviews.

The timeline for the project was very tight. FieldworkHub programmed the online survey in-house, and loaded the translated script provided by the client. We also expertly recruited both patients and nurses for the pilot interviews in less than a week, proceeding to obtain all targeted online completes in two weeks. We ensured to provide daily updates to our client throughout the programming and fielding process. In the final stages, we also delivered the raw data and an automated report to our client within 24 hours of closing the survey. The client was very pleased with the speed and responsiveness of the FieldworkHub team, and also with the quality of the insights that they obtained from our work together.